Endothelial safety of radiological contrast media: Why being concerned

Vascular Pharmacology

Volumn 58, Issue 1-2, 2013, Pages 48-53

  Scoditti, Egeria ^a   Massaro, Marika ^a   Montinari, Maria Rosa ^b  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b UNIVERSITY OF SALENTO   (Italy)

Author keywords

Apoptosis; Endothelial cells; Endothelium derived factors; Inflammation; Iodinated contrast media; Oxidative stress

Indexed keywords

CONTRAST MEDIUM; IODINATED CONTRAST MEDIUM; IODIXANOL;

CALCIUM HOMEOSTASIS; CELL STRUCTURE; CONTRAST INDUCED NEPHROPATHY; DRUG CYTOTOXICITY; DRUG DISTRIBUTION; DRUG STRUCTURE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; HYDROPHILICITY; HYPOXIA; KIDNEY BLOOD FLOW; KIDNEY MEDULLA; KIDNEY TUBULE PRESSURE; META ANALYSIS (TOPIC); NEPHROTOXICITY; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; RENOVASCULAR HYPERTENSION; REVIEW; VASCULAR ENDOTHELIUM; VASOCONSTRICTION;

ACUTE KIDNEY INJURY; ANIMALS; APOPTOSIS; CONTRAST MEDIA; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION; IODINE; OXIDATIVE STRESS; THROMBOSIS; VASOCONSTRICTION;

EID: 84871718639     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2012.10.004     Document Type: Review

References (59)

1. A.C.T.Investigators Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT). Circulation 2011, 124:1250-1259.
2. Agmon Y., Peleg H., Greenfeld Z., Rosen S., Brezis M. Nitric oxide and prostanoids protect the renal outer medulla from radiocontrast toxicity in the rat. J. Clin. Invest. 1994, 94:1069-1075.
3. Andreucci M., Lucisano G., Faga T., Bertucci B., Tamburrini O., Pisani A., Sabbatini M., Salzano S., Vitale M., Fuiano G., Michael A. Differential activation of signaling pathways involved in cell death, survival and inflammation by radiocontrast media in human renal proximal tubular cells. Toxicol. Sci. 2011, 119:408-416.
4. Aspelin P., Aubry P., Fransson S.G., Strasser R., Willenbrock R., Berg K.J. Nephrotoxic effects in high-risk patients undergoing angiography. N. Engl. J. Med. 2003, 348:491-499.
5. Aspelin P., Stacul F., Thomsen H.S., Morcos S.K., van der Molen A.J. Effects of iodinated contrast media on blood and endothelium. Eur. Radiol. 2006, 16:1041-1049.
6. Bakris G.L., Lass N., Gaber A.O., Jones J.D., Burnett J.C. Radiocontrast medium-induced declines in renal function: a role for oxygen free radicals. Am. J. Physiol. 1990, 258:F115-F120.
7. Barrett B.J., Carlisle E.J. Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 1993, 188:171-178.
8. Bertrand M.E., Esplugas E., Piessens J., Rasch W. Influence of a nonionic, iso-osmolar contrast medium (iodixanol) versus an ionic, low-osmolar contrast medium (ioxaglate) on major adverse cardiac events in patients undergoing percutaneous transluminal coronary angioplasty: a multicenter, randomized, double-blind study. Visipaque in Percutaneous Transluminal Coronary Angioplasty [VIP] Trial Investigators. Circulation 2000, 101:131-136.
9. Blann A.D., Adams R., Ashleigh R., Naser S., Kirkpatrick U., McCollum C.N. Changes in endothelial, leucocyte and platelet markers following contrast medium injection during angiography in patients with peripheral artery disease. Br. J. Radiol. 2001, 74:811-817.
10. Cowley A.W., Mori T., Mattson D., Zou A.P. Role of renal NO production in the regulation of medullary blood flow. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003, 284:R1355-R1369.
11. De Caterina R., Massaro M., Libby P. Endothelial functions and dysfunctions. Endothelial Dysfunctions and Vascular Disease 2007, 2-25. Blackwell Publishing Inc., Malden. R. De Caterina, P. Libby (Eds.).
12. Deanfield J.E., Halcox J.P., Rabelink T.J. Endothelial function and dysfunction: testing and clinical relevance. Circulation 2007, 115:1285-1295.
13. Devarajan P. Update on mechanisms of ischemic acute kidney injury. J. Am. Soc. Nephrol. 2006, 17:1503-1520.
14. Dong M., Jiao Z., Liu T., Guo F., Li G. Effect of administration route on the renal safety of contrast agents: a meta-analysis of randomized controlled trials. J. Nephrol. 2012, 25:290-301.
15. Drager L.F., Andrade L., Barros de Toledo J.F., Laurindo F.R., Machado Cesar L.A., Seguro A.C. Renal effects of N-acetylcysteine in patients at risk for contrast nephropathy: decrease in oxidant stress-mediated renal tubular injury. Nephrol. Dial. Transplant. 2004, 19:1803-1807.
16. Fauser C., Ullisch E.V., Kubler W., Haller C. Differential effects of radiocontrast agents on human umbilical vein endothelial cells: cytotoxicity and modulators of thrombogenicity. Eur. J. Med. Res. 2001, 6:465-472.
17. Fernandez-Rodriguez S., Edwards D.H., Newton B., Griffith T.M. Attenuated store-operated Ca2+ entry underpins the dual inhibition of nitric oxide and EDHF-type relaxations by iodinated contrast media. Cardiovasc. Res. 2009, 84:470-478.
18. Fiaccadori E., Maggiore U., Rotelli C., Giacosa R., Lombardi M., Sagripanti S., Buratti S., Ardissino D., Cabassi A. Plasma and urinary free 3-nitrotyrosine following cardiac angiography procedures with non-ionic radiocontrast media. Nephrol. Dial. Transplant. 2004, 19:865-869.
19. Forstermann U., Sessa W.C. Nitric oxide synthases: regulation and function. Eur. Heart J. 2012, 33:829-837. (837a-837d).
20. Franke R.P., Fuhrmann R., Hiebl B., Jung F. Influence of various radiographic contrast media on the buckling of endothelial cells. Microvasc. Res. 2008, 76:110-113.
21. From A.M., Al Badarin F.J., McDonald F.S., Bartholmai B.J., Cha S.S., Rihal C.S. Iodixanol versus low-osmolar contrast media for prevention of contrast induced nephropathy: meta-analysis of randomized, controlled trials. Circ. Cardiovasc. Interv. 2010, 3:351-358.
22. Hansen P.B., Hashimoto S., Oppermann M., Huang Y., Briggs J.P., Schnermann J. Vasoconstrictor and vasodilator effects of adenosine in the mouse kidney due to preferential activation of A1 or A2 adenosine receptors. J. Pharmacol. Exp. Ther. 2005, 315:1150-1157.
23. Heyman S.N., Clark B.A., Kaiser N., Spokes K., Rosen S., Brezis M., Epstein F.H. Radiocontrast agents induce endothelin release in vivo and in vitro. J. Am. Soc. Nephrol. 1992, 3:58-65.
24. Heyman S.N., Rosen S., Brezis M. Radiocontrast nephropathy: a paradigm for the synergism between toxic and hypoxic insults in the kidney. Exp. Nephrol. 1994, 2:153-157.
25. Heyman S.N., Rosen S., Khamaisi M., Idee J.M., Rosenberger C. Reactive oxygen species and the pathogenesis of radiocontrast-induced nephropathy. Invest. Radiol. 2010, 45:188-195.
26. Hsu S.P., Tsai T.J., Chien C.T. Ioxitalamate induces renal tubular apoptosis via activation of renal efferent nerve-mediated adrenergic signaling, renin activity, and reactive oxygen species production in rats. Toxicol. Sci. 2010, 114:149-158.
27. Hutcheson I.R., Griffith T.M., Pitman M.R., Towart R., Gregersen M., Refsum H., Karlsson J.O. Iodinated radiographic contrast media inhibit shear stress- and agonist-evoked release of NO by the endothelium. Br. J. Pharmacol. 1999, 128:451-457.
28. Kelly A.M., Dwamena B., Cronin P., Bernstein S.J., Carlos R.C. Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy. Ann. Intern. Med. 2008, 148:284-294.
29. Khamaisi M., Raz I., Shilo V., Shina A., Rosenberger C., Dahan R., Abassi Z., Meidan R., Lecht S., Heyman S.N. Diabetes and radiocontrast media increase endothelin converting enzyme-1 in the kidney. Kidney Int. 2008, 74:91-100.
30. Lee H.T., Jan M., Bae S.C., Joo J.D., Goubaeva F.R., Yang J., Kim M. A1 adenosine receptor knockout mice are protected against acute radiocontrast nephropathy in vivo. Am. J. Physiol. Renal Physiol. 2006, 290:F1367-F1375.
31. Limbruno U., Petronio A.S., Amoroso G., Baglini R., Paterni G., Merelli A., Mariotti R., Raffaele De C., Mariani M. The impact of coronary artery disease on the coronary vasomotor response to nonionic contrast media. Circulation 2000, 101:491-497.
32. Liss P., Carlsson P.O., Nygren A., Palm F., Hansell P. Et-A receptor antagonist BQ123 prevents radiocontrast media-induced renal medullary hypoxia. Acta Radiol. 2003, 44:111-117.
33. Malek A.M., Goss G.G., Jiang L., Izumo S., Alper S.L. Mannitol at clinical concentrations activates multiple signaling pathways and induces apoptosis in endothelial cells. Stroke 1998, 29:2631-2640.
34. Morcos S.K., Dawson P., Pearson J.D., Jeremy J.Y., Davenport A.P., Yates M.S., Tirone P., Cipolla P., de Haen C., Muschick P., Krause W., Refsum H., Emery C.J., Liss P., Nygren A., Haylor J., Pugh N.D., Karlsson J.O. The haemodynamic effects of iodinated water soluble radiographic contrast media: a review. Eur. J. Radiol. 1998, 29:31-46.
35. Morgan D.M., Bettmann M.A. Effects of X-ray contrast media and radiation on human vascular endothelial cells in vitro. Cardiovasc. Intervent. Radiol. 1989, 12:154-160.
36. Murakami R., Machida M., Tajima H., Hayashi H., Uchiyama N., Kumazaki T. Plasma endothelin, nitric oxide and atrial natriuretic peptide levels in humans after abdominal angiography. Acta Radiol. 2002, 43:340-343.
37. Nordby A., Tvedt K.E., Halgunset J., Haugen O.A. Intracellular penetration and accumulation of radiographic contrast media in the rat kidney. Scanning Microsc. 1990, 4:651-664. (discussion 664-656).
38. Perrin T., Descombes E., Cook S. Contrast-induced nephropathy in invasive cardiology. Swiss Med. Wkly. 2012, 142:w13608.
39. Pitman M.R., Karlsson J.O., Griffith T.M. Ionic mechanisms contributing to the vasorelaxant properties of iodinated contrast media: a comparison of iohexol and iodixanol in the rabbit isolated aorta. Br. J. Pharmacol. 1996, 119:685-690.
40. Prasad P.V., Priatna A., Spokes K., Epstein F.H. Changes in intrarenal oxygenation as evaluated by BOLD MRI in a rat kidney model for radiocontrast nephropathy. J. Magn. Reson. Imaging 2001, 13:744-747.
41. Pugh N.D., Hutcheson I.R., Edwards D.H., Nossen J.O., Karlsson J.O., Griffith T.M. Angiographic contrast media relax isolated rabbit aorta through an endothelium-independent mechanism that may not depend on the presence of the iodine atom. Br. J. Radiol. 1995, 68:23-26.
42. Quintavalle C., Brenca M., De Micco F., Fiore D., Romano S., Romano M.F., Apone F., Bianco A., Zabatta M.A., Troncone G., Briguori C., Condorelli G. In vivo and in vitro assessment of pathways involved in contrast media-induced renal cells apoptosis. Cell Death Dis. 2011, 2:e155.
43. Ramponi S., Grotti A., Morisetti A., Vultaggio S., Lorusso V. Effects of iodinated contrast media on endothelium: an in vitro study. Toxicol. In Vitro 2007, 21:191-196.
44. Riemann C.D., Massey C.V., McCarron D.L., Borkowski P., Johnson P.C., Ziskind A.A. Ionic contrast agent-mediated endothelial injury causes increased platelet deposition to vascular surfaces. Am. Heart J. 1993, 125:71-78.
45. Ronda N., Potì F., Palmisano A., Gatti R., Orlandini G., Maggiore U., Cabassi A., Regolisti G., Fiaccadori E. Effects of the radiocontrast agent iodixanol on endothelial cell morphology and function. Vasc. Pharmacol. 2013, 58:39-47. (this issue).
46. Rosati G. Clinical utility and safety profile of iomeprol. Eur. J. Radiol. 1994, 18(Suppl. 1):S120-S124.
47. Sandler C.M. Contrast-agent-induced acute renal dysfunction-is iodixanol the answer?. N. Engl. J. Med. 2003, 348:551-553.
48. Seeliger E., Sendeski M., Rihal C.S., Persson P.B. Contrast-induced kidney injury: mechanisms, risk factors, and prevention. Eur. Heart J. 2012, 33:2007-2015.
49. Sendeski M.M. Pathophysiology of renal tissue damage by iodinated contrast media. Clin. Exp. Pharmacol. Physiol. 2011, 38:292-299.
50. Solomon R.J., Mehran R., Natarajan M.K., Doucet S., Katholi R.E., Staniloae C.S., Sharma S.K., Labinaz M., Gelormini J.L., Barrett B.J. Contrast-induced nephropathy and long-term adverse events: cause and effect?. Clin. J. Am. Soc. Nephrol. 2009, 4:1162-1169.
51. Spargias K., Adreanides E., Demerouti E., Gkouziouta A., Manginas A., Pavlides G., Voudris V., Cokkinos D.V. Iloprost prevents contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation 2009, 120:1793-1799.
52. Tepel M., van der Giet M., Schwarzfeld C., Laufer U., Liermann D., Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N. Engl. J. Med. 2000, 343(3):180-184.
53. Wang Y.X., Emery C.J., Laude E., Morcos S.K. Effects of radiographic contrast media on the tension of isolated small pulmonary arteries. Br. J. Radiol. 1997, 70:1229-1238.
54. Wu C.T., Sheu M.L., Tsai K.S., Weng T.I., Chiang C.K., Liu S.H. The role of endoplasmic reticulum stress-related unfolded protein response in the radiocontrast medium-induced renal tubular cell injury. Toxicol. Sci. 2010, 114:295-301.
55. Zhang J., Duarte C.G., Ellis S. Contrast medium- and mannitol-induced apoptosis in heart and kidney of SHR rats. Toxicol. Pathol. 1999, 27:427-435.
56. Zhang H., Holt C.M., Malik N., Shepherd L., Morcos S.K. Effects of radiographic contrast media on proliferation and apoptosis of human vascular endothelial cells. Br. J. Radiol. 2000, 73:1034-1041.
57. Zhang T., Shen L.H., Hu L.H., He B. Statins for the prevention of contrast-induced nephropathy: a systematic review and meta-analysis. Am. J. Nephrol. 2011, 33:344-351.
58. Zhao J., Huang Y., Song Y., Zhao X., Jin J., Wang J., Huang L. Low osmolar contrast medium induces cellular injury and disruption of calcium homeostasis in rat glomerular endothelial cells in vitro. Toxicol. Lett. 2009, 185:124-131.
59. Zhao Y., Tao Z., Xu Z., Chen B., Wang L., Li C., Chen L., Jia Q., Jia E., Zhu T., Yang Z. Toxic effects of a high dose of non-ionic iodinated contrast media on renal glomerular and aortic endothelial cells in aged rats in vivo. Toxicol. Lett. 2011, 202:253-260.